Simplify Exchange Traded Funds (SURI)
운용사 · ARCX · 시리즈 S000078061 · SEC EDGAR에서 보기 ↗
이 펀드에 대한 보유 자산 데이터는 아직 사용할 수 없습니다.
이 페이지에서
펀드 흐름 (SEC 보고)
- 지난달 (3월 2026)
- -$1.4M
- 분기 종료 3월 2026
- -$756K
- 지난 12개월
- -$467K
4월 2025 – 3월 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
전체 구성 48 보유
| 이름 | CUSIP | 가치 | % | 잔액 | 카테고리 | 국가 |
|---|---|---|---|---|---|---|
| United States Treasury Bills | 912797TE7 | $64.5M | 92.93 | 65,000,000 | DBT | US |
| Plains GP Holdings LP | 72651A207 | $30.9M | 44.55 | 1,272,360 | EC | US |
| Achieve Life Science Inc | 004468500 | $3.5M | 5.02 | 1,184,512 | EC | US |
| Phathom Pharmaceuticals Inc | 71722W107 | $2.9M | 4.20 | 262,386 | EC | US |
| Delcath Systems Inc. | 24661P807 | $2.4M | 3.49 | 261,126 | EC | US |
| Abeona Therapeutics Inc. | 00289Y206 | $2.2M | 3.23 | 500,342 | EC | US |
| Celldex Therapeutics Inc. | 15117B202 | $2.2M | 3.16 | 68,994 | EC | US |
| Milestone Pharmaceuticals Inc | 59935V107 | $1.8M | 2.58 | 1,506,405 | EC | CA |
| Oculis Holding AG | — | $1.8M | 2.56 | 66,667 | EC | CH |
| LeonaBio Inc. | 04746L203 | $1.5M | 2.21 | 149,279 | EC | US |
| Corcept Therapeutics Inc. | 218352102 | $1.5M | 2.19 | 37,763 | EC | US |
| Kyverna Therapeutics Inc | 501976104 | $1.5M | 2.15 | 173,106 | EC | US |
| Inventiva SA | 46124U107 | $1.3M | 1.82 | 227,923 | EC | FR |
| Viridian Therapeutics Inc | 92790C104 | $1.1M | 1.59 | 56,231 | EC | US |
| Aquestive Therapeutics Inc | 03843E104 | $972K | 1.40 | 234,279 | EC | US |
| VOR BIOPHARMA INC | 929033207 | $955K | 1.38 | 53,510 | EC | US |
| Orchestra BioMed Holdings Inc | 68572M106 | $932K | 1.34 | 219,387 | EC | US |
| Zevra Therapeutics Inc | 488445206 | $897K | 1.29 | 96,246 | EC | US |
| Compass Pathways plc | 20451W101 | $880K | 1.27 | 159,052 | EC | GB |
| Telesat Canada /Telesat LLC | 87952VAR7 | $800K | 1.15 | 1,000,000 | DBT | CA |
| Trevi Therapeutics Inc | 89532M101 | $780K | 1.13 | 65,412 | EC | US |
| Ocular Therapeutix Inc | 67576A100 | $762K | 1.10 | 90,000 | EC | US |
| Sab Biotherapeutics Inc | 78397T202 | $717K | 1.03 | 187,230 | EC | US |
| Upstream Bio Inc | 91678A107 | $700K | 1.01 | 77,793 | EC | US |
| Eyepoint Inc. | 30233G209 | $690K | 0.99 | 53,526 | EC | US |
| 4D Molecular Therapeutics Inc | 35104E100 | $656K | 0.95 | 70,430 | EC | US |
| Palisade Bio Inc | 696389402 | $612K | 0.88 | 350,000 | EC | US |
| Zealand Pharma As | — | $569K | 0.82 | 12,330 | EC | DK |
| KALARIS THERAPEUTICS INC | 482929106 | $504K | 0.73 | 87,426 | EC | US |
| Immunic Inc. | 4525EP101 | $487K | 0.70 | 438,932 | EC | US |
| Coherus Oncology Inc. | 19249H103 | $428K | 0.62 | 253,140 | EC | US |
| Akero Therapeutics Inc | 009CVR044 | $427K | 0.62 | 145,609 | EC | US |
| Corvus Pharmaceuticals Inc | 221015100 | $296K | 0.43 | 20,242 | EC | US |
| Ovid Therapeutics Inc | 690469101 | $290K | 0.42 | 130,813 | EC | US |
| ARTIVA BIOTHERAPEUTICS INC | 04317A107 | $150K | 0.22 | 23,230 | EC | US |
| CONNECT BIOPHARMA HOLDINGS LTD | — | $140K | 0.20 | 53,375 | EC | KY |
| Chinook Therapeutics Inc | 169CVR016 | $2K | 0.00 | 25,000 | EC | US |
| Eiger BioPharmaceuticals Inc | 28249U204 | $900 | 0.00 | 90,000 | EC | US |
| MILESTONE PHARMACE WTS | — | $2 | 0.00 | 1,842,974 | EC | US |
| MILESTONE PHARMACE WTS | — | $2 | 0.00 | 1,842,974 | EC | US |
| Achieve Life Science Inc | 004468187 | $1 | 0.00 | 966,667 | EC | US |
| JASPER THERAPEUTIC WTS | — | $1 | 0.00 | 609,053 | EC | US |
| WTS - TENAYA THERAPEUTICS | — | $1 | 0.00 | 560,000 | EC | US |
| QUOIN PHARMACEUTIC WTS | — | $0 | 0.00 | 34,895 | EC | US |
| QUOIN PHARMACEUTIC WTS | — | $0 | 0.00 | 34,895 | EC | US |
| QUOIN PHARMACEUTIC WTS | — | $0 | 0.00 | 34,895 | EC | US |
| QUOIN PHARMACEUTIC WTS | — | $0 | 0.00 | 34,895 | EC | US |
| MORGAN STANLEY & CO. LLC | — | -$63.2M | -91.06 | -63,152,370 | RA | US |
기관 투자자 (13F) 1개의 제출자
분기별 SEC 양식 13F에 이 ETF 보유를 보고하는 기관. 롱 포지션만 해당; 단일 보고 의무자는 별도의 옵션 계약 건으로 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 기관 | 가치 | % 추적된 13F 중 | 주식 | 유형 | 기준일 |
|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | $221,164 | 100.00% | 12,359 | 주식 | 2026년 6월 30일 |
동종 펀드
규모 유사
| 펀드 | 운용 자산 규모 |
|---|---|
| GTR WisdomTree Trust | $69.5M |
| FINT Advisors' Inner Circle Fund II | $69.6M |
| BNDS Series Portfolios Trust | $69.7M |
| PQDI Principal Exchange-Traded Funds | $70.0M |
| OCTU AIM ETF Products Trust | $70.1M |
| EASG DBX ETF Trust | $69.1M |
| GAA Cambria ETF Trust | $68.9M |
| AVMA AMERICAN CENTURY ETF TRUST | $68.8M |
| LABD Direxion Shares ETF Trust | $68.1M |
| QCOC First Trust Exchange-Traded Fun… | $68.0M |